Ionis Pharmaceuticals in (ions 1.75 06/15/28)
13F holders, Q2 2024 (June 30)4holders
$1.10avg. 13F price*
At the end of Q2 2024, 4 institutions reported holding Ionis Pharmaceuticals in (ions 1.75 06/15/28) in their 13F filings. The largest holders were Jane Street Group, LLC ($23.9M), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.7M) and Liberty Mutual Group Asset Management Inc. ($2.2M).
- Company
- Ionis Pharmaceuticals in (ions 1.75 06/15/28)
- CUSIP
- 462222AF7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $29.1M |
| Exits | 0 | $0 |
Ownership 4 holders
| Jane Street Group, LLC | 0.03% | New | 21,797,000 | $23.9M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | New | 2,500,000 | $2.7M |
| Liberty Mutual Group Asset Management Inc. | 0.33% | New | 2,020,000 | $2.2M |
| Bank of New York Mellon Corp | 0.00% | New | 250,000 | $276K |
"% of holder's portfolio" is IONIS PHARMACEUTICALS IN (IONS 1.75 06/15/28)'s weight in each manager's 13F, not the share of Ionis Pharmaceuticals in (ions 1.75 06/15/28) the manager owns.